Biosimilars - The interchangeability debate

Shaju Backer is the former managing director of three Australian-based pharmaceutical companies and a Medicines Australia Board member. He writes that going too early, and rushing to increase their uptake, could ultimately undermine the long-term use of biosimilars. …